ADAKVEO
- Product NDC
- 0078-0883
- 11-digit product format
- 000780883
- Labeler code
- 0078
- Product ID
- 0078-0883_659b0142-cf3f-4af9-ad14-79f8c88978af
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- crizanlizumab
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- BLA761128
- Marketing category
- BLA
- Marketing start
- 2019-11-15
- Substance
- CRIZANLIZUMAB
- Active strength
- 10 mg/mL
- Pharmacologic classes
- P-Selectin Blockers [MoA], Selectin Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ADAKVEO
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CRIZANLIZUMAB | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | L7451S9126 |
| Rxcui | 2262425, 2262430 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0078-0883-61 | ADAKVEO | 10 mL in 1 VIAL, GLASS | INJECTION | 10 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0078-0883 | ADAKVEO (CRIZANLIZUMAB) INJECTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 6 | Current NDC, Legacy NDC, 1 package rows | 20240702_b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0078-0883-61 | 00078088361 | 10 mL in 1 VIAL, GLASS (0078-0883-61) | 10 ml | 2019-11-15 | 0000-00-00 | No | No | Current |